|
Founded: |
Ferring was first founded in Sweden in 1950 by Dr. Frederik Paulsen |
|
Headquarters: |
Saint-Prex, Switzerland |
|
International: |
Ferring International Center (Switzerland)
Two International PharmaScience Centres (Denmark and USA)
Production sites in eight countries (Argentina, China, Czech Republic, Denmark, Germany, Israel, Mexico and Switzerland).
Three R&D Centres (Denmark, Israel, USA) |
|
Market presence: |
In more than 45 countries |
|
Workforce: |
More than 3700 employees worldwide |
|
2009 sales: |
EUR 950 Million |
|
Growth: |
Double-digit average annual growth rate over the last two decades |
Key therapeutic areas and products
|
Urology: |
MINIRIN (desmopressin)* is the treatment of choice for bedwetting in children and nocturia in adults.
FIRMAGON (degarelix)* is a treatment for advanced hormone-dependent prostate cancer.
TESTIM (testosterone)** is an efficacious and convenient treatment for men suffering from low testosterone. |
|
Reproductive Health: |
MENOPUR (Menotropin)* (REPRONEX in the US) and BRAVELLE* (hFSH) are ovarian-stimulating treatments used in preparation for in-vitro fertilisation (IVF).
TRACTOCILE (Atosiban)* is used to treat pre-term (premature) labour. |
|
Endocrinology:
|
ZOMACTON (Somatropin)* is a recombinant human growth hormone used to treat growth failure in children. |
|
Gastroenterology: |
PENTASA (mesalazine)* is used for the treatment of inflammatory bowel diseases.
GLYPRESSIN (terlipressin)* for Bleeding Oesophageal Varices and (in some markets) for Hepatorenal syndrome. |
(* MINIRIN, FIRMAGON, MENOPUR, REPRONEX, BRAVELLE, TRACTOCILE, ZOMACTON, PENTASA and GLYPRESSIN are registered trademarks of Ferring BV and/or any of its affiliates.)
(**TESTIM is a registered trademark of Auxilium Pharmaceuticals, Inc. - Ferring markets TESTIM in Europe under license from Auxilium Pharmaceuticals, Inc.)